24 related articles for article (PubMed ID: 33085163)
1. Effects of pre- and post-natal treatment with KRN633, an inhibitor of vascular endothelial growth factor receptor tyrosine kinase, on retinal vascular development and patterning in mice.
Morita A; Nakahara T; Abe N; Kurauchi Y; Mori A; Sakamoto K; Nagamitsu T; Ishii K
Exp Eye Res; 2014 Mar; 120():127-37. PubMed ID: 24462631
[TBL] [Abstract][Full Text] [Related]
2. Retinal neuronal cell loss prevents abnormal retinal vascular growth in a rat model of retinopathy of prematurity.
Nakano A; Asano D; Kondo R; Mori A; Arima S; Ushikubo H; Sakamoto K; Nagamitsu T; Ishii K; Nakahara T
Exp Eye Res; 2018 Mar; 168():115-127. PubMed ID: 29339088
[TBL] [Abstract][Full Text] [Related]
3. Retinal vascular development is mediated by endothelial filopodia, a preexisting astrocytic template and specific R-cadherin adhesion.
Dorrell MI; Aguilar E; Friedlander M
Invest Ophthalmol Vis Sci; 2002 Nov; 43(11):3500-10. PubMed ID: 12407162
[TBL] [Abstract][Full Text] [Related]
4. Treatment of mid-pregnant mice with KRN633, an inhibitor of vascular endothelial growth factor receptor tyrosine kinase, induces abnormal retinal vascular patterning in their newborn pups.
Morita A; Nakahara T; Abe N; Kurauchi Y; Mori A; Sakamoto K; Nagamitsu T; Ishii K
Birth Defects Res B Dev Reprod Toxicol; 2014 Aug; 101(4):293-9. PubMed ID: 24831925
[TBL] [Abstract][Full Text] [Related]
5. Establishment of an abnormal vascular patterning model in the mouse retina.
Morita A; Sawada S; Mori A; Arima S; Sakamoto K; Nagamitsu T; Nakahara T
J Pharmacol Sci; 2018 Apr; 136(4):177-188. PubMed ID: 29627228
[TBL] [Abstract][Full Text] [Related]
6. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
Stalmans I
Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
[TBL] [Abstract][Full Text] [Related]
7. Development of the primate retinal vasculature.
Provis JM
Prog Retin Eye Res; 2001 Nov; 20(6):799-821. PubMed ID: 11587918
[TBL] [Abstract][Full Text] [Related]
8. Experimental models of growth factor-mediated angiogenesis and blood-retinal barrier breakdown.
Vinores SA; Seo MS; Okamoto N; Ash JD; Wawrousek EF; Xiao WH; Hudish T; Derevjanik NL; Campochiaro PA
Gen Pharmacol; 2000 Nov; 35(5):233-9. PubMed ID: 11888678
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity of different vascular beds in the eye to neovascularization and blood-retinal barrier breakdown in VEGF transgenic mice.
Vinores SA; Derevjanik NL; Vinores MA; Okamoto N; Campochiaro PA
Adv Exp Med Biol; 2000; 476():129-38. PubMed ID: 10949661
[TBL] [Abstract][Full Text] [Related]
10. Plexus-specific retinal vascular anatomy and pathologies as seen by projection-resolved optical coherence tomographic angiography.
Hormel TT; Jia Y; Jian Y; Hwang TS; Bailey ST; Pennesi ME; Wilson DJ; Morrison JC; Huang D
Prog Retin Eye Res; 2021 Jan; 80():100878. PubMed ID: 32712135
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological depletion of retinal neurons prevents vertical angiogenic sprouting without affecting the superficial vascular plexus.
Morita A; Yoshizumi M; Arima S; Mori A; Sakamoto K; Nagamitsu T; Nakahara T
Dev Dyn; 2021 Apr; 250(4):497-512. PubMed ID: 33085163
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
